The superiority of docetaxel based triplet therapy over standard care in patients with resectable esophago-gastric cancer has been confirmed in late-breaking results from the FLOT4 trial presented at ...
†In months; p-values stated when <0.05. ‡ All grade 3/4. Reported as percentages for the various arms, in the order mentioned in 'treatments'. § Only powered for noninferiority. 5-FU: 5-fluorouracil; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results